Michael H. Davidson - 25 Sep 2024 Form 3 Insider Report for BioAge Labs, Inc. (BIOA)

Reporting relationship: Director
Issuer ticker: BIOA
Reported as of: 25 Sep 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 25 Sep 2024, 16:51:11 UTC
Prior SEC filing: 22 Aug 2024
Next SEC filing: 11 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Dov A. Goldstein as attorney-in-fact

Key filing fact

Michael H. Davidson filed Form 3 for BioAge Labs, Inc. (BIOA) on 25 Sep 2024.

Key facts

This page summarizes Michael H. Davidson's Form 3 filing for BioAge Labs, Inc. (BIOA).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Sep 2024, 16:51.

Change

Previous filing in this sequence was filed on 22 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIOA holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 25 Sep 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 33,986
Exercise price: $8.39
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vested or vests as to 1/36th of the total award monthly, with the first tranche vesting on April 26, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.